{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T20:23:19Z","timestamp":1776025399980,"version":"3.50.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2005,10,25]],"date-time":"2005-10-25T00:00:00Z","timestamp":1130198400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"},{"start":{"date-parts":[[2005,10,25]],"date-time":"2005-10-25T00:00:00Z","timestamp":1130198400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                        <jats:title>Introduction<\/jats:title>\n                        <jats:p>Metaplastic breast carcinomas constitute a heterogeneous group of neoplasms, accounting for less than 1% of all invasive mammary carcinomas. Approximately 70\u201380% of metaplastic breast carcinomas overexpress the epidermal growth factor receptor (EGFR). Human epidermal growth factor receptor (HER)2 and EGFR have attracted much attention in the medical literature over the past few years owing to the fact that humanized monoclonal antibodies against HER2 and therapies directed against the extracellular ligand-binding domain or the intracellular tyrosine kinase domain of EGFR have proven successful in treating certain types of human cancer. We investigated whether HER2 and EGFR overexpression was present and evaluated gene amplification in a series of metaplastic breast carcinomas.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Method<\/jats:title>\n                        <jats:p>Twenty-five metaplastic breast carcinomas were immunohistochemically analyzed using a monoclonal antibody (31G7) for EGFR and two antibodies for HER2 (Herceptest and CB11) and scored using the Herceptest scoring system. Gene amplification was evaluated by chromogenic <jats:italic>in situ<\/jats:italic> hybridization using Zymed Spot-Light EGFR and HER2 amplification probe. The results were evaluated by bright field microscopy under 40\u00d7 and 63\u00d7 objective lenses.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Results<\/jats:title>\n                        <jats:p>Nineteen (76%) metaplastic breast carcinomas exhibited EGFR ovexpression, and among these EGFR amplification (defined either by large gene clusters or &gt;5 signals\/nucleus in &gt;50% of neoplastic cells) was detected in seven cases (37%): three carcinomas with squamous differentiation and four spindle cell carcinomas. One case exhibited HER2 overexpression of grade 2+ (&gt;10% of cells with weak to moderate complete membrane staining), but HER2 gene amplification was not detected.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Conclusion<\/jats:title>\n                        <jats:p>Metaplastic breast carcinomas frequently overexpressed EGFR, which was associated with EGFR gene amplification in one-third of cases. Our findings suggest that some patients with metaplastic breast carcinomas might benefit from novel therapies targeting EGFR. Because most metaplastic breast carcinomas overexpress EGFR without gene amplification, further studies to evaluate EGFR activating mutations are warranted.<\/jats:p>\n                     <\/jats:sec>","DOI":"10.1186\/bcr1341","type":"journal-article","created":{"date-parts":[[2005,10,26]],"date-time":"2005-10-26T06:13:50Z","timestamp":1130307230000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":127,"title":["Metaplastic breast carcinomas exhibit EGFR, but not HER2, gene amplification and overexpression: immunohistochemical and chromogenic in situ hybridization analysis"],"prefix":"10.1186","volume":"7","author":[{"given":"Jorge S","family":"Reis-Filho","sequence":"first","affiliation":[]},{"given":"Fernanda","family":"Milanezi","sequence":"additional","affiliation":[]},{"given":"Silvia","family":"Carvalho","sequence":"additional","affiliation":[]},{"given":"Pete T","family":"Simpson","sequence":"additional","affiliation":[]},{"given":"Dawn","family":"Steele","sequence":"additional","affiliation":[]},{"given":"Kay","family":"Savage","sequence":"additional","affiliation":[]},{"given":"Maryou BK","family":"Lambros","sequence":"additional","affiliation":[]},{"given":"Emilio M","family":"Pereira","sequence":"additional","affiliation":[]},{"given":"Jahn M","family":"Nesland","sequence":"additional","affiliation":[]},{"given":"Sunil R","family":"Lakhani","sequence":"additional","affiliation":[]},{"given":"Fernando C","family":"Schmitt","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2005,10,25]]},"reference":[{"key":"1320_CR1","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/nrc1609","volume":"5","author":"NE Hynes","year":"2005","unstructured":"Hynes NE, Lane HA: ERBB receptors and cancer: the complexity of targeted inhibitors. Nat Rev Cancer. 2005, 5: 341-354. 10.1038\/nrc1609.","journal-title":"Nat Rev Cancer"},{"key":"1320_CR2","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/path.1003","volume":"196","author":"Z Suo","year":"2002","unstructured":"Suo Z, Risberg B, Kalsson MG, Willman K, Tierens A, Skovlund E, Nesland JM: EGFR family expression in breast carcinomas. c-erbB-2 and c-erbB-4 receptors have different effects on survival. J Pathol. 2002, 196: 17-25. 10.1002\/path.1003.","journal-title":"J Pathol"},{"key":"1320_CR3","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1177\/106689690100900303","volume":"9","author":"Z Suo","year":"2001","unstructured":"Suo Z, Yang H, Mei Q, Skovlund E, Cui J, Nesland JM: Type 1 protein tyrosine kinases in Chinese breast carcinomas: a clinicopathologic study. Int J Surg Pathol. 2001, 9: 177-187.","journal-title":"Int J Surg Pathol"},{"key":"1320_CR4","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1080\/019131200750060032","volume":"24","author":"Z Suo","year":"2000","unstructured":"Suo Z, Nesland JM: Phyllodes tumor of the breast: EGFR family expression and relation to clinicopathological features. Ultrastruct Pathol. 2000, 24: 371-381. 10.1080\/019131200750060032.","journal-title":"Ultrastruct Pathol"},{"key":"1320_CR5","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1046\/j.1365-2559.1998.00498.x","volume":"33","author":"Z Suo","year":"1998","unstructured":"Suo Z, Emilsen E, Tveit KM, Nesland JM: Type 1 protein tyrosine kinases in benign and malignant breast lesions. Histopathology. 1998, 33: 514-521. 10.1046\/j.1365-2559.1998.00498.x.","journal-title":"Histopathology"},{"key":"1320_CR6","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1038\/sj.bjc.6602184","volume":"91","author":"DM Abd El-Rehim","year":"2004","unstructured":"Abd El-Rehim DM, Pinder SE, Paish CE, Bell JA, Rampaul RS, Blamey RW, Robertson JF, Nicholson RI, Ellis IO: Expression and co-expression of the members of the epidermal growth factor receptor (EGFR) family in invasive breast carcinoma. Br J Cancer. 2004, 91: 1532-42. 10.1038\/sj.bjc.6602184.","journal-title":"Br J Cancer"},{"key":"1320_CR7","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1200\/JCO.2005.09.055","volume":"23","author":"MP DiGiovanna","year":"2005","unstructured":"DiGiovanna MP, Stern DF, Edgerton SM, Whalen SG, Moore D, Thor AD: Relationship of epidermal growth factor receptor expression to ErbB-2 signaling activity and prognosis in breast cancer patients. J Clin Oncol. 2005, 23: 1152-1160. 10.1200\/JCO.2005.09.055.","journal-title":"J Clin Oncol"},{"key":"1320_CR8","volume-title":"Mod Pathol","author":"R Bhargava","year":"2005","unstructured":"Bhargava R, Gerald WL, Li AR, Pan Q, Lal P, Ladanyi M, Chen B: EGFR gene amplification in breast cancer: correlation with epidermal growth factor receptor mRNA and protein expression and HER-2 status and absence of EGFR-activating mutations. Mod Pathol. 2005."},{"key":"1320_CR9","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/0022-4731(89)90072-1","volume":"34","author":"AL Harris","year":"1989","unstructured":"Harris AL, Nicholson S, Sainsbury JR, Farndon J, Wright C: Epidermal growth factor receptors in breast cancer: association with early relapse and death, poor response to hormones and interactions with neu. J Steroid Biochem. 1989, 34: 123-131. 10.1016\/0022-4731(89)90072-1.","journal-title":"J Steroid Biochem"},{"key":"1320_CR10","first-page":"3454","volume":"8","author":"S Tsutsui","year":"2002","unstructured":"Tsutsui S, Kataoka A, Ohno S, Murakami S, Kinoshita J, Hachitanda Y: Prognostic and predictive value of epidermal growth factor receptor in recurrent breast cancer. Clin Cancer Res. 2002, 8: 3454-3460.","journal-title":"Clin Cancer Res"},{"key":"1320_CR11","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1023\/A:1006194700667","volume":"53","author":"RA Walker","year":"1999","unstructured":"Walker RA, Dearing SJ: Expression of epidermal growth factor receptor mRNA and protein in primary breast carcinomas. Breast Cancer Res Treat. 1999, 53: 167-176. 10.1023\/A:1006194700667.","journal-title":"Breast Cancer Res Treat"},{"key":"1320_CR12","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1136\/jcp.2004.025163","volume":"58","author":"S Leibl","year":"2005","unstructured":"Leibl S, Moinfar F: Metaplastic breast carcinomas are negative for Her-2 but frequently express EGFR (Her-1): potential relevance to adjuvant treatment with EGFR tyrosine kinase inhibitors?. J Clin Pathol. 2005, 58: 700-704. 10.1136\/jcp.2004.025163.","journal-title":"J Clin Pathol"},{"key":"1320_CR13","doi-asserted-by":"publisher","first-page":"3235","DOI":"10.1200\/JCO.2005.08.409","volume":"23","author":"G Giaccone","year":"2005","unstructured":"Giaccone G: Epidermal growth factor receptor inhibitors in the treatment of non-small-cell lung cancer. J Clin Oncol. 2005, 23: 3235-3242. 10.1200\/JCO.2005.08.409.","journal-title":"J Clin Oncol"},{"key":"1320_CR14","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.1200\/JCO.2005.11.890","volume":"23","author":"J Baselga","year":"2005","unstructured":"Baselga J, Arteaga CL: Critical update and emerging trends in epidermal growth factor receptor targeting in cancer. J Clin Oncol. 2005, 23: 2445-2459. 10.1200\/JCO.2005.11.890.","journal-title":"J Clin Oncol"},{"key":"1320_CR15","doi-asserted-by":"publisher","first-page":"13306","DOI":"10.1073\/pnas.0405220101","volume":"101","author":"W Pao","year":"2004","unstructured":"Pao W, Miller V, Zakowski M, Doherty J, Politi K, Sarkaria I, Singh B, Heelan R, Rusch V, Fulton L, et al: EGF receptor gene mutations are common in lung cancers from 'never smokers' and are associated with sensitivity of tumors to gefitinib and erlotinib. Proc Natl Acad Sci USA. 2004, 101: 13306-13311. 10.1073\/pnas.0405220101.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1320_CR16","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1126\/science.1099314","volume":"304","author":"JG Paez","year":"2004","unstructured":"Paez JG, Janne PA, Lee JC, Tracy S, Greulich H, Gabriel S, Herman P, Kaye FJ, Lindeman N, Boggon TJ, et al: EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science. 2004, 304: 1497-1500. 10.1126\/science.1099314.","journal-title":"Science"},{"key":"1320_CR17","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1056\/NEJMoa040938","volume":"350","author":"TJ Lynch","year":"2004","unstructured":"Lynch TJ, Bell DW, Sordella R, Gurubhagavatula S, Okimoto RA, Brannigan BW, Harris PL, Haserlat SM, Supko JG, Haluska FG, et al: Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med. 2004, 350: 2129-2139. 10.1056\/NEJMoa040938.","journal-title":"N Engl J Med"},{"key":"1320_CR18","doi-asserted-by":"publisher","first-page":"4265","DOI":"10.1200\/JCO.2005.04.173","volume":"23","author":"M Marty","year":"2005","unstructured":"Marty M, Cognetti F, Maraninchi D, Snyder R, Mauriac L, Tubiana-Hulin M, Chan S, Grimes D, Anton A, Lluch A, et al: Efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment: results of a randomized phase II trial by the M77001 study group. J Clin Oncol. 2005, 23: 4265-4274. 10.1200\/JCO.2005.04.173.","journal-title":"J Clin Oncol"},{"key":"1320_CR19","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1053\/j.seminoncol.2004.07.022","volume":"31","author":"J Baselga","year":"2004","unstructured":"Baselga J, Gianni L, Geyer C, Perez EA, Riva A, Jackisch C: Future options with trastuzumab for primary systemic and adjuvant therapy. Semin Oncol. 2004, 31: 51-57.","journal-title":"Semin Oncol"},{"key":"1320_CR20","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1093\/jnen\/63.4.314","volume":"63","author":"KB Fallon","year":"2004","unstructured":"Fallon KB, Palmer CA, Roth KA, Nabors LB, Wang W, Carpenter M, Banerjee R, Forsyth P, Rich K, Perry A: Prognostic value of 1p, 19q, 9p, 10q, and EGFR-FISH analyses in recurrent oligodendrogliomas. J Neuropathol Exp Neurol. 2004, 63: 314-322.","journal-title":"J Neuropathol Exp Neurol"},{"key":"1320_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00019606-200403000-00001","volume":"13","author":"A Marquez","year":"2004","unstructured":"Marquez A, Wu R, Zhao J, Tao J, Shi Z: Evaluation of epidermal growth factor receptor (EGFR) by chromogenic in situ hybridization (CISH) and immunohistochemistry (IHC) in archival gliomas using bright-field microscopy. Diagn Mol Pathol. 2004, 13: 1-8. 10.1097\/00019606-200403000-00001.","journal-title":"Diagn Mol Pathol"},{"key":"1320_CR22","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1093\/jnci\/dji112","volume":"97","author":"F Cappuzzo","year":"2005","unstructured":"Cappuzzo F, Hirsch FR, Rossi E, Bartolini S, Ceresoli GL, Bemis L, Haney J, Witta S, Danenberg K, Domenichini I, et al: Epidermal growth factor receptor gene and protein and gefitinib sensitivity in non-small-cell lung cancer. J Natl Cancer Inst. 2005, 97: 643-655.","journal-title":"J Natl Cancer Inst"},{"key":"1320_CR23","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/S1542-3565(03)00219-2","volume":"1","author":"T Takehana","year":"2003","unstructured":"Takehana T, Kunitomo K, Suzuki S, Kono K, Fujii H, Matsumoto Y, Ooi A: Expression of epidermal growth factor receptor in gastric carcinomas. Clin Gastroenterol Hepatol. 2003, 1: 438-445. 10.1016\/S1542-3565(03)00219-2.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1320_CR24","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1159\/000084183","volume":"26","author":"C Corzo","year":"2005","unstructured":"Corzo C, Tusquets I, Salido M, Corominas JM, Bellet M, Suarez M, Baro T, Fabregat X, Serrano S, Sole F: Characterization of HER1 (c-erbB1) status in locally advanced breast cancer using fluorescence in situ hybridization and immunohistochemistry. Tumour Biol. 2005, 26: 25-30. 10.1159\/000084183.","journal-title":"Tumour Biol"},{"key":"1320_CR25","doi-asserted-by":"publisher","first-page":"8534","DOI":"10.1158\/0008-5472.CAN-04-1945","volume":"64","author":"K Al-Kuraya","year":"2004","unstructured":"Al-Kuraya K, Schraml P, Torhorst J, Tapia C, Zaharieva B, Novotny H, Spichtin H, Maurer R, Mirlacher M, Kochli O, et al: Prognostic relevance of gene amplifications and coamplifications in breast cancer. Cancer Res. 2004, 64: 8534-8540. 10.1158\/0008-5472.CAN-04-1945.","journal-title":"Cancer Res"},{"key":"1320_CR26","first-page":"48A","volume-title":"Mod Pathol","author":"JS Reis-Filho","year":"2005","unstructured":"Reis-Filho JS, Milanezi F, Simpson P, Fulford LG, Steele D, Nesland JM, Pereira EM, Lakhani SR, Schmitt FC: Are metaplastic breast carcinomas basal-like tumours? [abstract]. Mod Pathol. 2005, 48A-"},{"key":"1320_CR27","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1016\/0046-8177(90)90151-T","volume":"21","author":"ES Wargotz","year":"1990","unstructured":"Wargotz ES, Norris HJ: Metaplastic carcinomas of the breast: V. Metaplastic carcinoma with osteoclastic giant cells. Hum Pathol. 1990, 21: 1142-1150. 10.1016\/0046-8177(90)90151-T.","journal-title":"Hum Pathol"},{"key":"1320_CR28","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1002\/1097-0142(19900115)65:2<272::AID-CNCR2820650215>3.0.CO;2-6","volume":"65","author":"ES Wargotz","year":"1990","unstructured":"Wargotz ES, Norris HJ: Metaplastic carcinomas of the breast. IV. Squamous cell carcinoma of ductal origin. Cancer. 1990, 65: 272-276.","journal-title":"Cancer"},{"key":"1320_CR29","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1002\/1097-0142(19891001)64:7<1490::AID-CNCR2820640722>3.0.CO;2-L","volume":"64","author":"ES Wargotz","year":"1989","unstructured":"Wargotz ES, Norris HJ: Metaplastic carcinomas of the breast. III. Carcinosarcoma. Cancer. 1989, 64: 1490-1499.","journal-title":"Cancer"},{"key":"1320_CR30","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/0046-8177(89)90065-8","volume":"20","author":"ES Wargotz","year":"1989","unstructured":"Wargotz ES, Deos PH, Norris HJ: Metaplastic carcinomas of the breast. II. Spindle cell carcinoma. Hum Pathol. 1989, 20: 732-740. 10.1016\/0046-8177(89)90065-8.","journal-title":"Hum Pathol"},{"key":"1320_CR31","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/0046-8177(89)90149-4","volume":"20","author":"ES Wargotz","year":"1989","unstructured":"Wargotz ES, Norris HJ: Metaplastic carcinomas of the breast. I. Matrix-producing carcinoma. Hum Pathol. 1989, 20: 628-635. 10.1016\/0046-8177(89)90149-4.","journal-title":"Hum Pathol"},{"key":"1320_CR32","first-page":"1078","volume":"73","author":"AG Huvos","year":"1973","unstructured":"Huvos AG, Lucas JC, Foote FW: Metaplastic breast carcinoma. Rare form of mammary cancer. N Y State J Med. 1973, 73: 1078-1082.","journal-title":"N Y State J Med"},{"key":"1320_CR33","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1097\/00000478-198712000-00002","volume":"11","author":"HA Oberman","year":"1987","unstructured":"Oberman HA: Metaplastic carcinoma of the breast. A clinicopathologic study of 29 patients. Am J Surg Pathol. 1987, 11: 918-929.","journal-title":"Am J Surg Pathol"},{"key":"1320_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/path.1806","volume":"207","author":"JS Reis-Filho","year":"2005","unstructured":"Reis-Filho JS, Simpson PT, Jones C, Steele D, Mackay A, Iravani M, Fenwick K, Valgeirsson H, Lambros M, Ashworth A, et al: Pleomorphic lobular carcinoma of the breast: role of comprehensive molecular pathology in characterization of an entity. J Pathol. 2005, 207: 1-13. 10.1002\/path.1806.","journal-title":"J Pathol"},{"key":"1320_CR35","doi-asserted-by":"publisher","first-page":"4793","DOI":"10.1158\/1078-0432.CCR-0428-03","volume":"10","author":"J Isola","year":"2004","unstructured":"Isola J, Tanner M, Forsyth A, Cooke TG, Watters AD, Bartlett JM: Interlaboratory comparison of HER-2 oncogene amplification as detected by chromogenic and fluorescence in situ hybridization. Clin Cancer Res. 2004, 10: 4793-4798. 10.1158\/1078-0432.CCR-0428-03.","journal-title":"Clin Cancer Res"},{"key":"1320_CR36","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1097\/01.MP.0000052102.90815.82","volume":"16","author":"M Bilous","year":"2003","unstructured":"Bilous M, Dowsett M, Hanna W, Isola J, Lebeau A, Moreno A, Penault-Llorca F, Ruschoff J, Tomasic G, van de Vijver M: Current perspectives on HER2 testing: a review of national testing guidelines. Mod Pathol. 2003, 16: 173-182. 10.1097\/01.MP.0000052102.90815.82.","journal-title":"Mod Pathol"},{"key":"1320_CR37","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1002\/ijc.20591","volume":"113","author":"JW Lee","year":"2005","unstructured":"Lee JW, Soung YH, Kim SY, Park WS, Nam SW, Lee JY, Yoo NJ, Lee SH: Absence of EGFR mutation in the kinase domain in common human cancers besides non-small cell lung cancer. Int J Cancer. 2005, 113: 510-511. 10.1002\/ijc.20591.","journal-title":"Int J Cancer"},{"key":"1320_CR38","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1038\/sj.bjc.6602557","volume":"92","author":"F Weber","year":"2005","unstructured":"Weber F, Fukino K, Sawada T, Williams N, Sweet K, Brena RM, Plass C, Caldes T, Mutter GL, Villalona-Calero MA, et al: Variability in organ-specific EGFR mutational spectra in tumour epithelium and stroma may be the biological basis for differential responses to tyrosine kinase inhibitors. Br J Cancer. 2005, 92: 1922-1926. 10.1038\/sj.bjc.6602557.","journal-title":"Br J Cancer"},{"key":"1320_CR39","doi-asserted-by":"publisher","first-page":"5367","DOI":"10.1158\/1078-0432.CCR-04-0220","volume":"10","author":"TO Nielsen","year":"2004","unstructured":"Nielsen TO, Hsu FD, Jensen K, Cheang M, Karaca G, Hu Z, Hernandez-Boussard T, Livasy C, Cowan D, Dressler L, et al: Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma. Clin Cancer Res. 2004, 10: 5367-5374. 10.1158\/1078-0432.CCR-04-0220.","journal-title":"Clin Cancer Res"},{"key":"1320_CR40","first-page":"29","volume":"10","author":"D Santini","year":"2002","unstructured":"Santini D, Ceccarelli C, Tardio ML, Taffurelli M, Marrano D: Immunocytochemical expression of epidermal growth factor receptor in myoepithelial cells of the breast. Appl Immunohistochem Mol Morphol. 2002, 10: 29-33. 10.1097\/00022744-200203000-00005.","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"1320_CR41","first-page":"1","volume":"11","author":"JS Reis-Filho","year":"2003","unstructured":"Reis-Filho JS, Milanezi F, Paredes J, Silva P, Pereira EM, Maeda SA, de Carvalho LV, Schmitt FC: Novel and classic myoepithelial\/stem cell markers in metaplastic carcinomas of the breast. Appl Immunohistochem Mol Morphol. 2003, 11: 1-8. 10.1097\/00022744-200303000-00001.","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"1320_CR42","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1046\/j.1365-2559.2003.01513_2.x","volume":"42","author":"JS Reis-Filho","year":"2003","unstructured":"Reis-Filho JS, Schmitt FC: p63 expression in sarcomatoid\/metaplastic carcinomas of the breast. Histopathology. 2003, 42: 94-95. 10.1046\/j.1365-2559.2003.01513_2.x.","journal-title":"Histopathology"},{"key":"1320_CR43","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1097\/01.pas.0000152133.60278.d2","volume":"29","author":"S Leibl","year":"2005","unstructured":"Leibl S, Gogg-Kammerer M, Sommersacher A, Denk H, Moinfar F: Metaplastic breast carcinomas: are they of myoepithelial differentiation?: immunohistochemical profile of the sarcomatoid subtype using novel myoepithelial markers. Am J Surg Pathol. 2005, 29: 347-353. 10.1097\/01.pas.0000152133.60278.d2.","journal-title":"Am J Surg Pathol"},{"key":"1320_CR44","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1053\/S0046-8177(03)00414-3","volume":"34","author":"B Dunne","year":"2003","unstructured":"Dunne B, Lee AH, Pinder SE, Bell JA, Ellis IO: An immunohistochemical study of metaplastic spindle cell carcinoma, phyllodes tumor and fibromatosis of the breast. Hum Pathol. 2003, 34: 1009-1015. 10.1053\/S0046-8177(03)00414-3.","journal-title":"Hum Pathol"},{"key":"1320_CR45","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1309\/G6CTR8MDTFUW19XV","volume":"120","author":"NK Popnikolov","year":"2003","unstructured":"Popnikolov NK, Ayala AG, Graves K, Gatalica Z: Benign myoepithelial tumors of the breast have immunophenotypic characteristics similar to metaplastic matrix-producing and spindle cell carcinomas. Am J Clin Pathol. 2003, 120: 161-167. 10.1309\/G6CT-R8MD-TFUW-19XV.","journal-title":"Am J Clin Pathol"},{"key":"1320_CR46","first-page":"1553","volume":"52","author":"A Sapino","year":"1992","unstructured":"Sapino A, Papotti M, Sanfilippo B, Gugliotta P, Bussolati G: Tumor types derived from epithelial and myoepithelial cell lines of R3230AC rat mammary carcinoma. Cancer Res. 1992, 52: 1553-1560.","journal-title":"Cancer Res"},{"key":"1320_CR47","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s10549-004-7260-y","volume":"91","author":"PJ Barnes","year":"2005","unstructured":"Barnes PJ, Boutilier R, Chiasson D, Rayson D: Metaplastic breast carcinoma: clinical-pathologic characteristics and HER2\/neu expression. Breast Cancer Res Treat. 2005, 91: 173-178. 10.1007\/s10549-004-7260-y.","journal-title":"Breast Cancer Res Treat"}],"container-title":["Breast Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/bcr1341.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/bcr1341\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/bcr1341.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T11:03:32Z","timestamp":1728385412000},"score":1,"resource":{"primary":{"URL":"https:\/\/breast-cancer-research.biomedcentral.com\/articles\/10.1186\/bcr1341"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10,25]]},"references-count":47,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2005,12]]}},"alternative-id":["1320"],"URL":"https:\/\/doi.org\/10.1186\/bcr1341","relation":{},"ISSN":["1465-542X"],"issn-type":[{"value":"1465-542X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,10,25]]},"assertion":[{"value":"17 July 2005","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2005","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2005","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2005","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"R1028"}}